• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Investigation of nasopharyngeal viral load at discharge in patients with COVID-19

tetano

Editor, Senior Moderator
J Infect Chemother


. 2021 Apr 8;S1341-321X(21)00104-5.
doi: 10.1016/j.jiac.2021.03.023. Online ahead of print.
Investigation of nasopharyngeal viral load at discharge in patients with COVID-19


Yasutaka Fukui[SUP] 1 [/SUP], Hitoshi Kawasuji[SUP] 1 [/SUP], Yusuke Taekgoshi[SUP] 1 [/SUP], Makito Kaneda[SUP] 1 [/SUP], Yushi Murai[SUP] 1 [/SUP], Kou Kimoto[SUP] 1 [/SUP], Akitoshi Ueno[SUP] 1 [/SUP], Yuki Miyajima[SUP] 1 [/SUP], Koyomi Kawago[SUP] 1 [/SUP], Ippei Sakamaki[SUP] 1 [/SUP], Yoshitomo Morinaga[SUP] 2 [/SUP], Yoshihiro Yamamoto[SUP] 3 [/SUP]



Affiliations

Abstract

This study aimed to assess the nasopharyngeal viral load at discharge or time of discontinued isolation in coronavirus 2019 (COVID-19) patients admitted to our hospital and discharged under the current symptom-based criteria in Japan. Patients diagnosed with COVID-19 by reverse transcription polymerase chain reaction and hospitalized at Toyama University Hospital were included in the analysis. Nasopharyngeal viral load was measured when symptom-based criteria for discharge or end of isolation in the accommodations were met, and examined the relationship between viral load and days after onset or age. From the perspective of virus isolation limit, the amount of infectious viral load was defined at 50 copies/?L by nasopharyngeal sample. Thirty-three patients with laboratory-confirmed COVID-19 were included in the analysis, after excluding critical and fatal cases. Mean nasopharyngeal viral load at discharge or end of isolation was 1.90 log-copies/?L, and 64% of patients were discharged with over 50 copies/?L. No correlation was apparent between age and viral load at discharge, and viral load remained relatively high at discharge or end of isolation in all age groups. Although attempts at infectious virus isolation are necessary, infection control precautions even after discharge or discontinued isolation in accommodations may be needed, as the date of onset mostly depended on self-reporting by patients.

Keywords: COVID-19; Infectivity; SARS-CoV-2; Viral load.
 
Back
Top Bottom